Does TIVOZANIB Cause Malignant neoplasm progression? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Malignant neoplasm progression have been filed in association with TIVOZANIB (FOTIVDA). This represents 3.6% of all adverse event reports for TIVOZANIB.
50
Reports of Malignant neoplasm progression with TIVOZANIB
3.6%
of all TIVOZANIB reports
9
Deaths
13
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TIVOZANIB?
Of the 50 reports, 9 (18.0%) resulted in death, 13 (26.0%) required hospitalization, and 1 (2.0%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TIVOZANIB. However, 50 reports have been filed with the FAERS database.
What Other Side Effects Does TIVOZANIB Cause?
Fatigue (291)
Diarrhoea (177)
Blood pressure increased (144)
Nausea (132)
Decreased appetite (127)
Disease progression (121)
Dysphonia (109)
Death (89)
Asthenia (80)
Off label use (73)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TIVOZANIB Alternatives Have Lower Malignant neoplasm progression Risk?
TIVOZANIB vs TIXOCORTOL PIVALATE
TIVOZANIB vs TIZANIDINE
TIVOZANIB vs TOBACCO LEAF
TIVOZANIB vs TOBRAMYCIN
TIVOZANIB vs TOBRAMYCIN\TOBRAMYCIN